Evasion from NK cell-mediated immune responses by HIV-1

Microbes and Infection

Volumn 14, Issue 11, 2012, Pages 904-915

  Jost, Stephanie ^a   Altfeld, Marcus ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Escape; HIV 1; Innate immunity; NK cells; Vaccine

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CD16 ANTIGEN; CD56 ANTIGEN; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2; NATURAL KILLER CELL RECEPTOR NKG2D; NEF PROTEIN; TOLL LIKE RECEPTOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VPU PROTEIN;

ALLELE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL SUBPOPULATION; CELLULAR IMMUNITY; DNA POLYMORPHISM; DOWN REGULATION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE EVASION; INNATE IMMUNITY; INTRAVENOUS DRUG ABUSE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SHORT SURVEY; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS SHEDDING;

HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; VIRAL VACCINES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84865560190     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.05.001     Document Type: Short Survey

References (121)

1. UNAIDS/WHO World AIDS Day Report 2011 2011, http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/JC2216_WorldAIDSday_report_2011_en.pdf.
2. Kim J.H., Rerks-Ngarm S., Excler J.L., Michael N.L. HIV vaccines: lessons learned and the way forward. Curr. Opin. HIV AIDS 2010, 5:428-434.
3. Pulendran B., Ahmed R. Immunological mechanisms of vaccination. Nat. Immunol. 2011, 12:509-517.
4. Andrews D.M., Estcourt M.J., Andoniou C.E., Wikstrom M.E., Khong A., Voigt V., Fleming P., Tabarias H., Hill G.R., van der Most R.G., Scalzo A.A., Smyth M.J., Degli-Esposti M.A. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 2010, 207:1333-1343.
5. Cooper M.A., Fehniger T.A., Fuchs A., Colonna M., Caligiuri M.A. NK cell and DC interactions. Trends Immunol. 2004, 25:47-52.
6. Robbins S.H., Bessou G., Cornillon A., Zucchini N., Rupp B., Ruzsics Z., Sacher T., Tomasello E., Vivier E., Koszinowski U.H., Dalod M. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog. 2007, 3:e123.
7. Waggoner S.N., Cornberg M., Selin L.K., Welsh R.M. Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012, 481:394-398.
8. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., Wilson M., O'Brien S.J., Carrington M. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 2002, 31:429-434.
9. Martin M.P., Qi Y., Gao X., Yamada E., Martin J.N., Pereyra F., Colombo S., Brown E.E., Shupert W.L., Phair J., Goedert J.J., Buchbinder S., Kirk G.D., Telenti A., Connors M., O'Brien S.J., Walker B.D., Parham P., Deeks S.G., McVicar D.W., Carrington M. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 2007, 39:733-740.
10. Alter G., Heckerman D., Schneidewind A., Fadda L., Kadie C.M., Carlson J.M., Oniangue-Ndza C., Martin M., Li B., Khakoo S.I., Carrington M., Allen T.M., Altfeld M. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 2011, 476:96-100.
11. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 2005, 23:225-274.
12. Arnon T.I., Markel G., Mandelboim O. Tumor and viral recognition by natural killer cells receptors. Semin. Cancer Biol. 2006, 16:348-358.
13. Hershkovitz O., Jivov S., Bloushtain N., Zilka A., Landau G., Bar-Ilan A., Lichtenstein R.G., Campbell K.S., van Kuppevelt T.H., Porgador A. Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry (Moscow) 2007, 46:7426-7436.
14. Hershkovitz O., Jarahian M., Zilka A., Bar-Ilan A., Landau G., Jivov S., Tekoah Y., Glicklis R., Gallagher J.T., Hoffmann S.C., Zer H., Mandelboim O., Watzl C., Momburg F., Porgador A. Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool. Glycobiology 2008, 18:28-41.
15. Hecht M.L., Rosental B., Horlacher T., Hershkovitz O., De Paz J.L., Noti C., Schauer S., Porgador A., Seeberger P.H. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J. Proteome Res. 2009, 8:712-720.
16. Bloushtain N., Qimron U., Bar-Ilan A., Hershkovitz O., Gazit R., Fima E., Korc M., Vlodavsky I., Bovin N.V., Porgador A. Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46. J. Immunol. 2004, 173:2392-2401.
17. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001, 409:1055-1060.
18. Arnon T.I., Lev M., Katz G., Chernobrov Y., Porgador A., Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 2001, 31:2680-2689.
19. Arnon T.I., Achdout H., Levi O., Markel G., Saleh N., Katz G., Gazit R., Gonen-Gross T., Hanna J., Nahari E., Porgador A., Honigman A., Plachter B., Mevorach D., Wolf D.G., Mandelboim O. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 2005, 6:515-523.
20. Mavoungou E., Held J., Mewono L., Kremsner P.G. A duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells. J. Infect. Dis. 2007, 195:1521-1531.
21. Simhadri V.R., Reiners K.S., Hansen H.P., Topolar D., Simhadri V.L., Nohroudi K., Kufer T.A., Engert A., Pogge von Strandmann E. Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PloS One 2008, 3:e3377.
22. Pogge von Strandmann E., Simhadri V.R., von Tresckow B., Sasse S., Reiners K.S., Hansen H.P., Rothe A., Boll B., Simhadri V.L., Borchmann P., McKinnon P.J., Hallek M., Engert A. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 2007, 27:965-974.
23. Brandt C.S., Baratin M., Yi E.C., Kennedy J., Gao Z., Fox B., Haldeman B., Ostrander C.D., Kaifu T., Chabannon C., Moretta A., West R., Xu W., Vivier E., Levin S.D. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 2009, 206:1495-1503.
24. Esin S., Batoni G., Counoupas C., Stringaro A., Brancatisano F.L., Colone M., Maisetta G., Florio W., Arancia G., Campa M. Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infect. Immun. 2008, 76:1719-1727.
25. Hershkovitz O., Rosental B., Rosenberg L.A., Navarro-Sanchez M.E., Jivov S., Zilka A., Gershoni-Yahalom O., Brient-Litzler E., Bedouelle H., Ho J.W., Campbell K.S., Rager-Zisman B., Despres P., Porgador A. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J. Immunol. 2009, 183:2610-2621.
26. Bashirova A.A., Thomas R., Carrington M. HLA/KIR restraint of HIV: surviving the fittest. Annu. Rev. Immunol. 2011, 29:295-317.
27. Stewart C.A., Laugier-Anfossi F., Vely F., Saulquin X., Riedmuller J., Tisserant A., Gauthier L., Romagne F., Ferracci G., Arosa F.A., Moretta A., Sun P.D., Ugolini S., Vivier E. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:13224-13229.
28. Brown D., Trowsdale J., Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004, 64:215-225.
29. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., Allan D.S., Makadzange A., Rowland-Jones S., Willcox B., Jones E.Y., van der Merwe P.A., Kumagai I., Maenaka K. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8856-8861.
30. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol. 2001, 22:633-640.
31. Trinchieri G., Valiante N. Receptors for the Fc fragment of IgG on natural killer cells. Nat. Immunol. 1993, 12:218-234.
32. Hart O.M., Athie-Morales V., O'Connor G.M., Gardiner C.M. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J. Immunol. 2005, 175:1636-1642.
33. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 2002, 168:4531-4537.
34. Sivori S., Falco M., Della Chiesa M., Carlomagno S., Vitale M., Moretta L., Moretta A. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10116-10121.
35. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
36. Meier A., Alter G., Frahm N., Sidhu H., Li B., Bagchi A., Teigen N., Streeck H., Stellbrink H.J., Hellman J., van Lunzen J., Altfeld M. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J. Virol. 2007, 81:8180-8191.
37. Beignon A.S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D.G., Larsson M., Gorelick R.J., Lifson J.D., Bhardwaj N. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 2005, 115:3265-3275.
38. Alter G., Suscovich T.J., Teigen N., Meier A., Streeck H., Brander C., Altfeld M. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J. Immunol. 2007, 178:7658-7666.
39. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001, 97:3146-3151.
40. Caligiuri M.A., Zmuidzinas A., Manley T.J., Levine H., Smith K.A., Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J. Exp. Med. 1990, 171:1509-1526.
41. Romagnani C., Juelke K., Falco M., Morandi B., D'Agostino A., Costa R., Ratto G., Forte G., Carrega P., Lui G., Conte R., Strowig T., Moretta A., Munz C., Thiel A., Moretta L., Ferlazzo G. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 2007, 178:4947-4955.
42. Chan A., Hong D.L., Atzberger A., Kollnberger S., Filer A.D., Buckley C.D., McMichael A., Enver T., Bowness P. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J. Immunol. 2007, 179:89-94.
43. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., Marcenaro E., Bottino C., Moretta L., Moretta A., Fauci A.S. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15011-15016.
44. Alter G., Teigen N., Davis B.T., Addo M.M., Suscovich T.J., Waring M.T., Streeck H., Johnston M.N., Staller K.D., Zaman M.T., Yu X.G., Lichterfeld M., Basgoz N., Rosenberg E.S., Altfeld M. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005, 106:3366-3369.
45. Mavilio D., Lombardo G., Benjamin J., Kim D., Follman D., Marcenaro E., O'Shea M.A., Kinter A., Kovacs C., Moretta A., Fauci A.S. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2886-2891.
46. Alter G., Martin M.P., Teigen N., Carr W.H., Suscovich T.J., Schneidewind A., Streeck H., Waring M., Meier A., Brander C., Lifson J.D., Allen T.M., Carrington M., Altfeld M. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 2007, 204:3027-3036.
47. Alter G., Rihn S., Walter K., Nolting A., Martin M., Rosenberg E.S., Miller J.S., Carrington M., Altfeld M. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J. Virol. 2009, 83:6798-6805.
48. Vivian J.P., Duncan R.C., Berry R., O'Connor G.M., Reid H.H., Beddoe T., Gras S., Saunders P.M., Olshina M.A., Widjaja J.M., Harpur C.M., Lin J., Maloveste S.M., Price D.A., Lafont B.A., McVicar D.W., Clements C.S., Brooks A.G., Rossjohn J. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 2011, 479:401-405.
49. Long B.R., Ndhlovu L.C., Oksenberg J.R., Lanier L.L., Hecht F.M., Nixon D.F., Barbour J.D. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J. Virol. 2008, 82:4785-4792.
50. O'Connell K.A., Han Y., Williams T.M., Siliciano R.F., Blankson J.N. Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro. J. Virol. 2009, 83:5028-5034.
51. Gaudieri S., DeSantis D., McKinnon E., Moore C., Nolan D., Witt C.S., Mallal S.A., Christiansen F.T. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun. 2005, 6:683-690.
52. Boulet S., Kleyman M., Kim J.Y., Kamya P., Sharafi S., Simic N., Bruneau J., Routy J.P., Tsoukas C.M., Bernard N.F. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS 2008, 22:1487-1491.
53. Boulet S., Song R., Kamya P., Bruneau J., Shoukry N.H., Tsoukas C.M., Bernard N.F. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J. Immunol. 2010, 184:2057-2064.
54. Kamya P., Boulet S., Tsoukas C.M., Routy J.P., Thomas R., Cote P., Boulassel M.R., Baril J.G., Kovacs C., Migueles S.A., Connors M., Suscovich T.J., Brander C., Tremblay C.L., Bernard N. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57. J. Virol. 2011, 85:5949-5960.
55. Pelak K., Need A.C., Fellay J., Shianna K.V., Feng S., Urban T.J., Ge D., De Luca A., Martinez-Picado J., Wolinsky S.M., Martinson J.J., Jamieson B.D., Bream J.H., Martin M.P., Borrow P., Letvin N.L., McMichael A.J., Haynes B.F., Telenti A., Carrington M., Goldstein D.B., Alter G. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol. 2011, 9:e1001208.
56. Scott-Algara D., Truong L.X., Versmisse P., David A., Luong T.T., Nguyen N.V., Theodorou I., Barre-Sinoussi F., Pancino G. Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J. Immunol. 2003, 171:5663-5667.
57. Tomescu C., Duh F.M., Lanier M.A., Kapalko A., Mounzer K.C., Martin M.P., Carrington M., Metzger D.S., Montaner L.J. Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users. AIDS 2010, 24:2151-2160.
58. Ravet S., Scott-Algara D., Bonnet E., Tran H.K., Tran T., Nguyen N., Truong L.X., Theodorou I., Barre-Sinoussi F., Pancino G., Paul P. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 2007, 109:4296-4305.
59. Montoya C.J., Velilla P.A., Chougnet C., Landay A.L., Rugeles M.T. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin. Immunol. 2006, 120:138-146.
60. Parsons M.S., Boulet S., Song R., Bruneau J., Shoukry N.H., Routy J.P., Tsoukas C.M., Bernard N.F. Mind the gap: lack of association between KIR3DL1*004/HLA-Bw4-induced natural killer cell function and protection from HIV infection. J. Infect. Dis. 2010, 202(Suppl. 3):S356-S360.
61. Boulet S., Sharafi S., Simic N., Bruneau J., Routy J.P., Tsoukas C.M., Bernard N.F. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 2008, 22:595-599.
62. Jennes W., Verheyden S., Demanet C., Adje-Toure C.A., Vuylsteke B., Nkengasong J.N., Kestens L. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J. Immunol. 2006, 177:6588-6592.
63. Iannello A., Debbeche O., Samarani S., Ahmad A. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. J. Leukoc. Biol. 2008, 84:1-26.
64. Brunetta E., Hudspeth K.L., Mavilio D. Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes. J. Leukoc. Biol. 2010, 88:1119-1130.
65. Eger K.A., Unutmaz D. Perturbation of natural killer cell function and receptors during HIV infection. Trends Microbiol. 2004, 12:301-303.
66. Shah A.H., Sowrirajan B., Davis Z.B., Ward J.P., Campbell E.M., Planelles V., Barker E. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 2010, 8:397-409.
67. Ward J., Bonaparte M., Sacks J., Guterman J., Fogli M., Mavilio D., Barker E. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 2007, 110:1207-1214.
68. Parsons M.S., Wren L., Isitman G., Navis M., Stratov I., Bernard N.F., Kent S.J. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. J. Virol. 2012, 86:4488-4495.
69. Liu Q., Sun Y., Rihn S., Nolting A., Tsoukas P.N., Jost S., Cohen K., Walker B., Alter G. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection. J. Virol. 2009, 83:8705-8712.
70. Chung A.W., Isitman G., Navis M., Kramski M., Center R.J., Kent S.J., Stratov I. Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7505-7510.
71. Alter G., Kavanagh D., Rihn S., Luteijn R., Brooks D., Oldstone M., van Lunzen J., Altfeld M. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. J. Clin. Invest. 2010, 120:1905-1913.
72. Quaranta M.G., Napolitano A., Sanchez M., Giordani L., Mattioli B., Viora M. HIV-1 Nef impairs the dynamic of DC/NK crosstalk: different outcome of CD56(dim) and CD56(bright) NK cell subsets. FASEB J. 2007, 21:2323-2334.
73. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999, 10:661-671.
74. Collins K.L., Chen B.K., Kalams S.A., Walker B.D., Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998, 391:397-401.
75. Le Gall S., Erdtmann L., Benichou S., Berlioz-Torrent C., Liu L., Benarous R., Heard J.M., Schwartz O. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 1998, 8:483-495.
76. Guma M., Angulo A., Lopez-Botet M. NK cell receptors involved in the response to human cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 2006, 298:207-223.
77. Bonaparte M.I., Barker E. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 2004, 104:2087-2094.
78. Bonaparte M.I., Barker E. Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS 2003, 17:487-494.
79. Ward J.P., Bonaparte M.I., Barker E. HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts. AIDS 2004, 18:1769-1779.
80. Fausther-Bovendo H., Sol-Foulon N., Candotti D., Agut H., Schwartz O., Debre P., Vieillard V. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. AIDS 2009, 23:1077-1087.
81. Vieillard V., Strominger J.L., Debre P. NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10981-10986.
82. Carroll I.R., Wang J., Howcroft T.K., Singer D.S. HIV Tat represses transcription of the beta 2-microglobulin promoter. Mol. Immunol. 1998, 35:1171-1178.
83. Kerkau T., Bacik I., Bennink J.R., Yewdell J.W., Hunig T., Schimpl A., Schubert U. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J. Exp. Med. 1997, 185:1295-1305.
84. Martini F., Agrati C., D'Offizi G., Poccia F. HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells. Int. J. Immunopathol. Pharmacol. 2005, 18:269-276.
85. Nattermann J., Nischalke H.D., Hofmeister V., Kupfer B., Ahlenstiel G., Feldmann G., Rockstroh J., Weiss E.H., Sauerbruch T., Spengler U. HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir. Ther. 2005, 10:95-107.
86. Derrien M., Pizzato N., Dolcini G., Menu E., Chaouat G., Lenfant F., Barre-Sinoussi F., Bouteiller P.L. Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1. J. Gen. Virol. 2004, 85:1945-1954.
87. Lozano J.M., Gonzalez R., Kindelan J.M., Rouas-Freiss N., Caballos R., Dausset J., Carosella E.D., Pena J. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002, 16:347-351.
88. Cabello A., Rivero A., Garcia M.J., Lozano J.M., Torre-Cisneros J., Gonzalez R., Duenas G., Galiani M.D., Camacho A., Santamaria M., Solana R., Montero C., Kindelan J.M., Pena J. HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals. Hum. Immunol. 2003, 64:1045-1049.
89. Champsaur M., Lanier L.L. Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 2010, 235:267-285.
90. Fogli M., Mavilio D., Brunetta E., Varchetta S., Ata K., Roby G., Kovacs C., Follmann D., Pende D., Ward J., Barker E., Marcenaro E., Moretta A., Fauci A.S. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog. 2008, 4:e1000101.
91. Norman J.M., Mashiba M., McNamara L.A., Onafuwa-Nuga A., Chiari-Fort E., Shen W., Collins K.L. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat. Immunol. 2011, 12:975-983.
92. Cerboni C., Neri F., Casartelli N., Zingoni A., Cosman D., Rossi P., Santoni A., Doria M. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J. Gen. Virol. 2007, 88:242-250.
93. Laguette N., Bregnard C., Benichou S., Basmaciogullari S. Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins. Mol. Aspects Med. 2010, 31:418-433.
94. Nolting A., Dugast A.S., Rihn S., Luteijn R., Carrington M.F., Kane K., Jost S., Toth I., Nagami E., Faetkenheuer G., Hartmann P., Altfeld M., Alter G. MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction. Virology 2010, 406:12-20.
95. Planelles V., Barker E. Roles of Vpr and Vpx in modulating the virus-host cell relationship. Mol. Asp. Med. 2010, 31:398-406.
96. Richard J., Sindhu S., Pham T.N., Belzile J.P., Cohen E.A. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 2010, 115:1354-1363.
97. Ward J., Davis Z., DeHart J., Zimmerman E., Bosque A., Brunetta E., Mavilio D., Planelles V., Barker E. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog. 2009, 5:e1000613.
98. Wissing S., Galloway N.L., Greene W.C. HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors. Mol. Asp. Med. 2010, 31:383-397.
99. Gasser S., Orsulic S., Brown E.J., Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005, 436:1186-1190.
100. Sousa M.M., Krokan H.E., Slupphaug G. DNA-uracil and human pathology. Mol. Asp. Med. 2007, 28:276-306.
101. Kaufman D.S., Schoon R.A., Leibson P.J. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:8337-8341.
102. Malnati M.S., Lusso P., Ciccone E., Moretta A., Moretta L., Long E.O. Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements. J. Exp. Med. 1993, 178:961-969.
103. Fadda L., Borhis G., Ahmed P., Cheent K., Pageon S.V., Cazaly A., Stathopoulos S., Middleton D., Mulder A., Claas F.H., Elliott T., Davis D.M., Purbhoo M.A., Khakoo S.I. Peptide antagonism as a mechanism for NK cell activation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:10160-10165.
104. Rajagopalan S., Long E.O. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 1997, 185:1523-1528.
105. Hansasuta P., Dong T., Thananchai H., Weekes M., Willberg C., Aldemir H., Rowland-Jones S., Braud V.M. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur. J. Immunol. 2004, 34:1673-1679.
106. Mandelboim O., Wilson S.B., Vales-Gomez M., Reyburn H.T., Strominger J.L. Self and viral peptides can initiate lysis by autologous natural killer cells. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4604-4609.
107. Zappacosta F., Borrego F., Brooks A.G., Parker K.C., Coligan J.E. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:6313-6318.
108. Boyington J.C., Brooks A.G., Sun P.D. Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules. Immunol. Rev. 2001, 181:66-78.
109. Peruzzi M., Parker K.C., Long E.O., Malnati M.S. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J. Immunol. 1996, 157:3350-3356.
110. Malnati M.S., Peruzzi M., Parker K.C., Biddison W.E., Ciccone E., Moretta A., Long E.O. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995, 267:1016-1018.
111. Peruzzi M., Wagtmann N., Long E.O. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J. Exp. Med. 1996, 184:1585-1590.
112. Thananchai H., Gillespie G., Martin M.P., Bashirova A., Yawata N., Yawata M., Easterbrook P., McVicar D.W., Maenaka K., Parham P., Carrington M., Dong T., Rowland-Jones S. Cutting Edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 2007, 178:33-37.
113. Brackenridge S., Evans E.J., Toebes M., Goonetilleke N., Liu M.K., di Gleria K., Schumacher T.N., Davis S.J., McMichael A.J., Gillespie G.M. An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1. J. Virol. 2011, 85:5415-5422.
114. Fadda L., O'Connor G.M., Kumar S., Piechocka-Trocha A., Gardiner C.M., Carrington M., McVicar D.W., Altfeld M. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J. Virol. 2011, 85:5970-5974.
115. Lopez M., Soriano V., Benito J.M. Escape mutations in HIV infection and its impact on CD8+ T cell responses. Curr. Mol. Med. 2007, 7:446-458.
116. Brumme Z.L., Brumme C.J., Carlson J., Streeck H., John M., Eichbaum Q., Block B.L., Baker B., Kadie C., Markowitz M., Jessen H., Kelleher A.D., Rosenberg E., Kaldor J., Yuki Y., Carrington M., Allen T.M., Mallal S., Altfeld M., Heckerman D., Walker B.D. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J. Virol. 2008, 82:9216-9227.
117. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2001, 2:951-956.
118. Gillard G.O., Bivas-Benita M., Hovav A.H., Grandpre L.E., Panas M.W., Seaman M.S., Haynes B.F., Letvin N.L. Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes. PLoS Pathog. 2011, 7:e1002141.
119. O'Leary J.G., Goodarzi M., Drayton D.L., von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 2006, 7:507-516.
120. Paust S., Gill H.S., Wang B.Z., Flynn M.P., Moseman E.A., Senman B., Szczepanik M., Telenti A., Askenase P.W., Compans R.W., von Andrian U.H. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 2010, 11:1127-1135.
121. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561.